Krystal Biotech Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $32.7M | $626.3M | $341.2M |
| FY2022 | $36.2M | $558.5M | $161.9M |
| FY2023 | $39.7M | $818.4M | $358.3M |
| FY2024 | $109.5M | $1.06B | $344.9M |
| FY2025 | $114.2M | $1.33B | $496.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $32.7M | $626.3M | $341.2M |
| FY2022 | $36.2M | $558.5M | $161.9M |
| FY2023 | $39.7M | $818.4M | $358.3M |
| FY2024 | $109.5M | $1.06B | $344.9M |
| FY2025 | $114.2M | $1.33B | $496.3M |